Drawing for CERENOME

USPTO serial 99902520

CERENOME

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with CERENOME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

PAOLO ANTONIO STRINO

PAOLO ANTONIO STRINO FBT GibbonsOne Pennsylvania PlazaNew York, NY 10119United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; radiopharmaceutical preparations for diagnostic and therapeutic purposes; diagnostic preparations for medical purposes for the detection and characterization of cancer and other diseases, including diseases and disorders of the central nervous system.ACTIVE—
042Medical research in the field of oncology; medical research laboratory services in the field of oncology; pharmaceutical research and development services; providing medical and scientific information in the field of cancer, diseases and disorders of the central nervous system, and oncological diseases and disorders; data analytics services in the field of oncology and central nervous system diseases and disorders; software as a service (SAAS) services featuring software for data analytics in the fields of pharmaceutical research, oncology, and diseases and disorders of the central nervous system; providing scientific and research information in the field of oncology and central nervous system diseases and disorders via a website.ACTIVE—
044Medical diagnostic testing services in the field of oncology and diseases of the central nervous system; providing medical information in the field of cancer diagnosis and treatment; providing medical information services in the field of oncology and central nervous system diseases and disorders, including through data analytics; providing healthcare data analytics services, namely, analysis of clinical and medical data in the fields of oncology and diseases and disorders of the central nervous system.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 24, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 24, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance